Using Real-World Evidence to Achieve High Quality Care that Improves Payer Outcomes for Multiple Sclerosis
Reserve your spot today for this Satellite Breakfast Symposium


Jointly provided by Partners for Advancing Clinical Education (PACE) and Impact Education, LLC.
Partners for Advancing Clinical Education (PACE)     Impact Education, LLC
This activity is supported by independent educational grants from Sanofi and Novartis Pharmaceuticals Corporation.
Thursday, March 23, 2023
6:00 AM - 6:30 AM - Registration and Breakfast
6:30 AM - 8:00 AM - Program
Henry B. Gonzalez Convention Center
San Antonio, TX


Please note: Registration for AMCP 2023 is NOT required to attend this symposium.


Click here to download the slides from this symposium.

Please join us for an encore presentation on Tuesday, April 18, 2023 from 12:00pm - 1:30pm ET. For more information and to register click here.
  Learn About
  • The impact and unique challenges of health equity in MS
  • How current and emerging therapies impact disease control
  • Hot the value of real-world evidence is interpreted to inform appropriate access
  Expert Faculty Presenters
Dana McCormick, RPh, FAMCP
Director of Pharmacy
Blue Cross Blue Shield of Texas
Mitzi Joi Williams, MD
Founder and CEO
Joi Life Wellness Group
  Who Should Attend?

This activity is designed to meet the educational needs of managed care pharmacy directors, registered nurses, clinical pharmacists, quality directors and medical directors.

  Statement of Need/Program Overview

Multiple sclerosis (MS) onset typically occurs in the prime of life, between the ages of 20 and 40 years, with women affected approximately twice as often as men. MS is the leading cause of non-traumatic disability in young adults. This symposium highlights opportunities for managed care and specialty pharmacy professionals to enhance disease state knowledge and administrative competencies to manage health plan patients with MS resulting in optimal clinical and economic outcomes.

  Educational Objectives

At the conclusion of this activity, participants should be able to demonstrate improved ability to:
  • Review the impact of health equity and the unique challenges presented by MS in diverse patient populations
  • Assess how current and emerging therapies impact disease control in diverse patient populations and their fit into the MS treatment algorithm
  • Interpret the value of real-world evidence to inform appropriate access and reimbursement decisions for patients with MS
  • Illustrate collaborative treatment optimization approaches to balance costs with improved outcomes for the management of MS
  Agenda

Date and Time
Thursday, March 23, 2023
6:00 AM - 6:30 AM - Registration and Breakfast
6:30 AM - 8:00 AM - Program
Henry B. Gonzalez Convention Center
San Antonio, TX

6:00 AM Registration and Breakfast
6:30 AM Pre-Activity Learning Assessment and Opening Comments
Dana McCormick, RPh, FAMCP
6:35 AM Clinical Overview of MS: Optimizing Treatment Selection in Diverse Patient Populations
Mitzi Joi Williams, MD
7:00 AM Using Real-World Evidence to Inform Appropriate Access and Reimbursement
Dana McCormick, RPh, FAMCP
7:25 AM Medical and Pharmacy Management Strategies to Enhance MS Outcomes for all Patient Types: A Case-Based Discussion
Dana McCormick, RPh, FAMCP and Mitzi Joi Williams, MD
7:40 AM Audience Q&A Session
7:55 AM Key Takeaways and Closing Comments; Post-Activity Assessment and Evaluation
8:00 AM Adjournment
  Accreditation Information
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (PACE) and Impact Education, LLC. PACE is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Education
PACE designates this live activity for a maximum of 1.5 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Pharmacy Education
PACE designates this continuing education activity for 1.5 contact hours (0.15 CEUs) of the Accreditation Council for Pharmacy Education.

UAN: JA4008073-9999-23-019-L01-P
Type of Activity: Knowledge


Disclosure of Conflicts of Interest
PACE requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial relationships they may have with ineligible companies. All relevant financial relationships are thoroughly vetted and mitigated according to PACE policy. PACE is committed to providing learners with high-quality accredited CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Americans with Disabilities Act
♿ Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact Impact Education, LLC, prior to the live event at (215) 619-8812.

Fee Information
No additional fee is required to attend this CPE/CME activity.

Please note: Registration for AMCP 2023 is NOT required to attend this symposium.

Walk-in registration will be available at the time of the program.
If you have any questions, please call (215) 619-8812 or email info@impactedu.net.